[HTML][HTML] Advances in the antimicrobial treatment of osteomyelitis

C Zhong, Y Wu, H Lin, R Liu - Composites Part B: Engineering, 2023 - Elsevier
Osteomyelitis is a major complication of orthopedic diseases with high recurrence and
morbidity, along with long hospital stays and high medical costs. The conventional treatment …

Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis

J Zakhour, SL Sharara, JR Hindy, SF Haddad, SS Kanj - Antibiotics, 2022 - mdpi.com
Pseudomonas aeruginosa is a pathogen often encountered in a healthcare setting. It has
consistently ranked among the most frequent pathogens seen in nosocomial infections …

A retrospective, observational study of 12 cases of expanded-access customized phage therapy: production, characteristics, and clinical outcomes

SI Green, JR Clark, HH Santos… - Clinical Infectious …, 2023 - academic.oup.com
Background Antimicrobial resistance (AMR) is undermining modern medicine, a problem
compounded by bacterial adaptation to antibiotic pressures. Phages are viruses that infect …

Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics

Q Chen, T Dharmaraj, PC Cai, EB Burgener… - Pharmaceutics, 2022 - mdpi.com
Bacteriophages, viruses that infect and replicate within bacteria, impact bacterial responses
to antibiotics in complex ways. Recent studies using lytic bacteriophages to treat bacterial …

Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram …

R Larcher, P Laffont-Lozes, C Roger… - Frontiers in Cellular …, 2022 - frontiersin.org
Introduction Novel last resort beta-lactam antibiotics are now available for management of
infections due to New-Delhi Metallo-Beta-Lactamase (NDM) producing Enterobacterales …

Phage therapy as a novel therapeutic for the treatment of bone and joint infections

GA Suh, T Ferry, MP Abdel - Clinical Infectious Diseases, 2023 - academic.oup.com
Solutions for bone and joint infection (BJI) are needed where conventional treatments are
inadequate. Bacteriophages (phages) are naturally occurring viruses that infect bacteria and …

Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University

S Würstle, A Lee, KE Kortright, F Winzig, W An… - Scientific Reports, 2024 - nature.com
Bacteriophage therapy is one potential strategy to treat antimicrobial resistant or persistent
bacterial infections, and the year 2021 marked the centennial of Felix d'Hérelle's first …

Engineering Phages to Fight Multidrug-Resistant Bacteria

H Peng, IA Chen, U Qimron - Chemical Reviews, 2024 - ACS Publications
Facing the global “superbug” crisis due to the emergence and selection for antibiotic
resistance, phages are among the most promising solutions. Fighting multidrug-resistant …

Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

H Onallah, R Hazan, R Nir-Paz, MJ Brownstein… - Med, 2023 - cell.com
Background A growing number of compassionate phage therapy cases were reported in the
last decade, with a limited number of clinical trials conducted and few unsuccessful clinical …

Human Complement Inhibits Myophages against Pseudomonas aeruginosa

JE Egido, SO Dekker, C Toner-Bartelds, C Lood… - Viruses, 2023 - mdpi.com
Therapeutic bacteriophages (phages) are primarily chosen based on their in vitro
bacteriolytic activity. Although anti-phage antibodies are known to inhibit phage infection …